Viewing Study NCT00069160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-06-06 @ 12:57 AM
Study NCT ID: NCT00069160
Status: COMPLETED
Last Update Posted: 2012-10-12
First Post: 2003-09-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Neoplasms View
None Ovarian Neoplasms View
None Cervix Neoplasms View
None Renal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacokinetics View
None Pharmacodynamics View
None Multidrug Resistance Reversal View
None Molecular Target View
None P-Glycoprotein Inhibition View
None Lung Cancer View
None Ovarian Cancer View
None Cervical Cancer View
None Renal Cancer View